Background: Clopidogrel use as single antiplatelet therapy (SAPT) has never been evaluated in stable coronary artery disease (CAD) outpatients either as compared to placebo or aspirin. <
PurposeTo identify the most important factors affecting physician decision-making regarding antiplatelet therapy. MethodsWe retrospectively gathered data from minor ischemic stroke patients with NIHSS
BackgroundPatients with cirrhosis and acute myocardial infarction (AMI) present dilemma whether dual antiplatelet therapy (DAPT) should be used.MethodsElectronic medical records between 2001–2013 were